Age group | |
---|---|
30-40years | 34/100 |
41-50years | 66/100 |
Tumor size (pathologic) | |
T1 | 64/100 |
T2 | 36/100 |
Lymph node involvement (pathologic) | |
N0 | 55/100 |
N1 | 45/100 |
Grade | Â |
G1 | 9/100 |
G2 | 62/100 |
G3 | 29/100 |
Estrogen receptors (ER) | |
ER positive | 57/100 |
ER negative | 43/100 |
Progestin receptors (PR) | |
PR positive | 48/100 |
PR negative | 52/100 |
Human epidermal growth factor receptor 2 (HER2) | |
HER2 positive | 28/100 |
HER2 negative | 72/100 |
Intrinsic subtype | |
Luminal A | 46/100 |
Luminal B | 18/100 |
HER2 enriched | 10/100 |
‘Basal-like’ | 26/100 |